Free Trial

Genocea Biosciences (GNCA) Short Interest Ratio & Short Volume

Genocea Biosciences logo

Genocea Biosciences Short Interest Data

Genocea Biosciences (GNCA) has a short interest of 3.59 million shares, representing 13.58% of the float (the number of shares available for trading by the public). This marks a 118.90% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 83,499 shares to cover all short positions.

Current Short Interest
3,590,000 shares
Previous Short Interest
1,640,000 shares
Change Vs. Previous Month
+118.90%
Dollar Volume Sold Short
$218.99 thousand
Short Interest Ratio
0.4 Days to Cover
Last Record Date
May 31, 2022
Outstanding Shares
58,730,000 shares
Float Size
26,440,000 shares
Short Percent of Float
13.58%
Today's Trading Volume
0 shares
Average Trading Volume
83,499 shares
Today's Volume Vs. Average
0%
Short Selling Genocea Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genocea Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNCA Short Interest Over Time

GNCA Days to Cover Over Time

GNCA Percentage of Float Shorted Over Time

Genocea Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20223,590,000 shares $218.99 thousand +118.9%13.6%0.4 $0.06
5/15/20221,640,000 shares $369 thousand -12.3%4.0%0.7 $0.23
4/30/20221,870,000 shares $529.77 thousand -37.0%4.5%1.1 $0.28
4/15/20222,970,000 shares $1.37 million +106.3%7.2%1.9 $0.46
3/31/20221,440,000 shares $1.80 million +5.1%3.5%4.3 $1.25
3/15/20221,370,000 shares $1.52 million +3.0%3.4%2.6 $1.11
2/28/20221,330,000 shares $1.30 million -1.5%3.3%2.5 $0.98
2/15/20221,350,000 shares $1.51 million -2.9%3.3%2.6 $1.12
1/31/20221,390,000 shares $1.47 million -5.4%3.4%2.6 $1.06
1/15/20221,470,000 shares $1.51 million -8.1%3.5%2.7 $1.03
12/31/20211,600,000 shares $1.86 million +8.8%3.8%3 $1.16
12/15/20211,470,000 shares $1.43 million -2.0%3.6%3.1 $0.97
11/30/20211,500,000 shares $2.03 million -4.5%3.6%8.2 $1.35
11/15/20211,570,000 shares $2.56 million -0.6%3.8%8.1 $1.63
10/29/20211,580,000 shares $3.02 million +6.8%3.8%8.4 $1.91
10/15/20211,480,000 shares $2.60 million No Change3.6%8.5 $1.76
9/30/20211,480,000 shares $2.84 million +0.7%3.6%8.4 $1.92
9/15/20211,470,000 shares $2.62 million +1.4%3.6%9.3 $1.78
8/31/20211,450,000 shares $2.55 million No Change3.5%9.4 $1.76
8/13/20211,450,000 shares $2.62 million -1.4%3.5%8 $1.81
7/30/20211,470,000 shares $2.97 million -3.3%3.6%7.3 $2.02
7/15/20211,520,000 shares $3.22 million -0.7%3.9%6.5 $2.12
6/30/20211,530,000 shares $3.58 million -1.9%4.0%5.8 $2.34
6/15/20211,560,000 shares $3.88 million -4.3%4.0%5.4 $2.49
5/28/20211,630,000 shares $3.85 million -5.2%4.2%5.1 $2.36
5/14/20211,720,000 shares $3.54 million -2.8%N/A5.5 $2.06
4/30/20211,770,000 shares $4.71 million +9.9%N/A4.2 $2.66
4/15/20211,610,000 shares $4.03 million No ChangeN/A3.2 $2.50
3/31/20211,610,000 shares $4.19 million -3.6%N/A2.8 $2.60
3/15/20211,670,000 shares $4.94 million +10.6%N/A2.8 $2.96
2/26/20211,510,000 shares $4.50 million -10.7%N/A2.5 $2.98
2/12/20211,690,000 shares $5.54 million -5.6%N/A2.9 $3.28
1/29/20211,790,000 shares $5.23 million +6.6%N/A3.3 $2.92
1/15/20211,680,000 shares $4.96 million +3.1%N/A3.6 $2.95
12/31/20201,630,000 shares $4.29 million No ChangeN/A4.7 $2.63
12/15/20201,630,000 shares $3.44 million -4.7%N/A4.8 $2.11
11/30/20201,710,000 shares $3.56 million +5.6%N/A4.4 $2.08
11/15/20201,620,000 shares $3.35 million -14.3%N/A4.1 $2.07
10/30/20201,890,000 shares $4.01 million +12.5%N/A4.4 $2.12
10/15/20201,680,000 shares $4.27 million -4.0%N/A1.9 $2.54
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
9/30/20201,750,000 shares $4.01 million -46.0%N/A1.5 $2.29
9/15/20203,240,000 shares $8.78 million +2.9%13.2%2.8 $2.71
8/31/20203,150,000 shares $7.62 million +30.7%12.8%2.9 $2.42
8/14/20202,410,000 shares $6.63 million +234.7%16.8%2.1 $2.75
7/31/2020720,000 shares $2.05 million +147.2%5.0%0.6 $2.85
7/15/2020291,300 shares $562.21 thousand +25.8%1.6%0.4 $1.93

GNCA Short Interest - Frequently Asked Questions

What is Genocea Biosciences' current short interest?

Short interest is the volume of Genocea Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 3,590,000 shares of GNCA short. 13.58% of Genocea Biosciences' shares are currently sold short. Learn More on Genocea Biosciences' current short interest.

What is a good short interest percentage for Genocea Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.58% of Genocea Biosciences' floating shares are currently sold short.

Is Genocea Biosciences' short interest increasing or decreasing?

Genocea Biosciences saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 3,590,000 shares, an increase of 118.9% from the previous total of 1,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Genocea Biosciences' float size?

Genocea Biosciences currently has issued a total of 58,730,000 shares. Some of Genocea Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genocea Biosciences currently has a public float of 26,440,000 shares.

How does Genocea Biosciences' short interest compare to its competitors?

13.58% of Genocea Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genocea Biosciences: Scopus BioPharma Inc. (0.03%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Aridis Pharmaceuticals, Inc. (0.00%), Calithera Biosciences, Inc. (0.43%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), Clever Leaves Holdings Inc. (0.52%), eFFECTOR Therapeutics, Inc. (0.13%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.12 billion), Palo Alto Networks, Inc. ($3.85 billion), Lucid Group, Inc. ($2.66 billion), HP Inc. ($2.31 billion), Coinbase Global, Inc. ($2.14 billion), GameStop Corp. ($1.94 billion), T. Rowe Price Group, Inc. ($1.91 billion), Chesapeake Energy Co. ($1.79 billion), Rivian Automotive, Inc. ($1.62 billion), and Carnival Corporation ($1.59 billion). View all of the most shorted stocks.

What does it mean to sell short Genocea Biosciences stock?

Short selling GNCA is an investing strategy that aims to generate trading profit from Genocea Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genocea Biosciences?

A short squeeze for Genocea Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNCA, which in turn drives the price of the stock up even further.

How often is Genocea Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNCA, twice per month. The most recent reporting period available is May, 31 2022.




This page (NASDAQ:GNCA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners